Cannabis Treatment Made Aged Rat Brains Look More Like Young Brains in Key Memory Region

Aged rats treated with EU-certified cannabis showed hippocampal tissue resembling young adults, with reduced neuroinflammation, while motor performance was unaffected.

Tudorancea, Ivona-Maria et al.·Journal of cannabis research·2025·Preliminary Evidencepreclinical
RTHC-07830PreclinicalPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
preclinical
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Chronic intermittent cannabis treatment (6 weeks) produced hippocampal histology resembling young adults. Modulated astrocyte function, reduced neuroinflammation markers. Dose-dependent effects. Motor performance and anxiety unaffected.

Key Numbers

Two doses: 6.25 and 25 mg/kg. 6-week treatment. Hippocampal tissue resembled young adults. Dose-dependent neuroinflammation effects.

How They Did This

Aged rats received EU-GMP certified Cannabis sativa at 6.25 and 25 mg/kg for 6 weeks. Histopathology, immunohistochemistry, and behavioral testing.

Why This Research Matters

As cannabis use among older adults rises, this suggests cannabis may have neuroprotective properties in aging, particularly in the hippocampus.

The Bigger Picture

Cannabinoid supplementation might partially restore youthful brain function in aging.

What This Study Doesn't Tell Us

Exploratory. Small sample. Rat model. Complex phytochemistry. Short duration.

Questions This Raises

  • ?Would longer treatment sustain neuroprotective effects?
  • ?Do older cannabis users show better cognitive preservation?

Trust & Context

Key Stat:
Evidence Grade:
EU-GMP certified product with multiple endpoints, but exploratory design and small sample.
Study Age:
2025 preclinical study of cannabis in naturally aged rats.
Original Title:
Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.
Published In:
Journal of cannabis research, 7(1), 53 (2025)
Database ID:
RTHC-07830

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can cannabis protect the aging brain?

In rats, cannabis made the hippocampus look more like young adult tissue. Preliminary findings needing human confirmation.

Is cannabis safe for older adults?

Generally safe in this rat study with no motor impairment, but human data in elderly remains limited.

Read More on RethinkTHC

Cite This Study

RTHC-07830·https://rethinkthc.com/research/RTHC-07830

APA

Tudorancea, Ivona-Maria; Stanciu, Gabriela-Dumitrita; Solcan, Carmen; Ciorpac, Mitica; Szilagyi, Andrei; Ababei, Daniela-Carmen; Gogu, Raluca-Maria; Tamba, Bogdan-Ionel. (2025). Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.. Journal of cannabis research, 7(1), 53. https://doi.org/10.1186/s42238-025-00313-8

MLA

Tudorancea, Ivona-Maria, et al. "Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.." Journal of cannabis research, 2025. https://doi.org/10.1186/s42238-025-00313-8

RethinkTHC

RethinkTHC Research Database. "Exploring the impact of chronic intermittent EU-GMP certifie..." RTHC-07830. Retrieved from https://rethinkthc.com/research/tudorancea-2025-exploring-the-impact-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.